Suggestions
Share
Journal Information

Statistics

Follow this link to access the full text of the article

ORIGINALS
Analysing criteria for price and reimbursement of orphan drugs in Spain
Análisis de los criterios sobre precio y financiación de los medicamentos huérfanos en España
Xavier Badia1,
Corresponding author
xbadia@omakaseconsulting.com

Author of correspondence Xavier Badia Llach, Omakase Consulting, C/ Enteza 332-334, 08039 Barcelona, Spain.
, Alicia Gil2, José Luis Poveda-Andrés3, John Shepherd4, Marina Tort4
1 CEO at Omakase Consulting, Barcelona. Spain.
2 Partner & CEO Market Access at Omakase Consulting, Barcelona. Spain.
3 Hospital Pharmacist, Hospital Universitario y Politécnico La Fe, Valencia. Spain.
4 Consultant at Omakase Consulting, Barcelona. Spain.
Read
3673
Times
was read the article
765
Total PDF
2908
Total HTML
Share statistics
Article information
ISSN: 11306343
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 196 39 235
2025 11 443 58 501
2025 10 236 46 282
2025 9 209 48 257
2025 8 240 40 280
2025 7 160 43 203
2025 6 115 20 135
2025 5 153 25 178
2025 4 109 15 124
2025 3 143 17 160
2025 2 102 18 120
2025 1 57 21 78
2024 12 84 16 100
2024 11 66 67 133
2024 10 63 44 107
2024 9 59 21 80
2024 8 61 33 94
2024 7 79 23 102
2024 6 89 42 131
2024 5 45 32 77
2024 4 45 26 71
2024 3 45 12 57
2024 2 38 16 54
2024 1 29 9 38
2023 12 21 18 39
2023 11 21 16 37
Show all

Follow this link to access the full text of the article

Idiomas
Farmacia Hospitalaria